FHIR IG analytics| Package | fhir.nwgenomics.nhs.uk |
| Resource Type | Questionnaire |
| Id | Questionnaire-HRDTumourBRCAAskAtOrderEntry.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/nw-gmsa/nw-gmsa.github.com/Questionnaire-HRDTumourBRCAAskAtOrderEntry.html |
| URL | https://fhir.nwgenomics.nhs.uk/Questionnaire/HRDTumourBRCAAskAtOrderEntry |
| Version | 2.2.0 |
| Status | unknown |
| Date | 2026-09-27T08:17:18+00:00 |
| Title | HRD and Tumour BRCA Ask At Order Entry Questions |
| Realm | us |
| Authority | hl7 |
| Description | **For analysis purposes only - not an active or planned project.** **Ask At Order Entry Questions** for the NW GLH paper **HRD and Tumour BRCA Test Request Form** (GB-27189), used alongside the [common core order form](Questionnaire-GenomicTestOrder.html) - see [Order Entry Questions](Questionnaire-GenomicTestOrder.html#order-entry-questions). This form is specific to newly-diagnosed advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer (HRD test, performed by Myriad Genetics Inc. in the United States) and its relapsed-disease tumour BRCA-only pathway. |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Questionnaire HRDTumourBRCAAskAtOrderEntry
Profile: Questionnaire
| LinkID | Text | Cardinality | Type | Description & Constraints |
|---|---|---|---|---|
  | **For analysis purposes only - not an active or planned project.** **Ask At Order Entry Questions** for the NW GLH paper **HRD and Tumour BRCA Test Request Form** (GB-27189), used alongside the [common core order form](Questionnaire-GenomicTestOrder.html) - see [Order Entry Questions](Questionnaire-GenomicTestOrder.html#order-entry-questions). This form is specific to newly-diagnosed advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer (HRD test, performed by Myriad Genetics Inc. in the United States) and its relapsed-disease tumour BRCA-only pathway. | Questionnaire | https://fhir.nwgenomics.nhs.uk/Questionnaire/HRDTumourBRCAAskAtOrderEntry#2.2.0 | |
  Patient | Patient details | 0..1 | group | Definition: Patient |
  LN/45392-8 | Forename | 0..1 | string | Definition: Patient.name.given |
| LN/45394-4 | Surname | 0..1 | string | Definition: Patient.name.family |
 LN/21112-8 | DoB (DD/MM/YY) | 0..1 | date | Definition: Patient.birthDate |
 LN/46098-0 | Sex | 0..1 | choice | Definition: Patient.gender Value Set: AdministrativeGender |
| LN/89061-6 | NHS number | 0..1 | string | Definition: Patient.identifier:nhsNumber |
 LN/76435-7 | Hospital number | 0..1 | string | Definition: Patient.identifier:MedicalRecordNumber |
| HealthcareProfessional | Referrers details | 0..1 | group | Definition: PractitionerRole |
| LN/18705-4 | Name | 0..1 | string | Definition: PractitionerRole.practitioner.display |
| NOS/ReferrerPosition | Position | 0..1 | string | |
 NOS/ReferrerPosition-designNote | No clean FHIR field identified for the referrer's job title, as distinct from their clinical specialty/department below. | 0..1 | display | |
| HL7/ORC-21 | NHS hospital | 0..1 | string | Definition: PractitionerRole.organization.identifier.value |
| LN/18707-0 | Department | 0..1 | choice | Definition: PractitionerRole.specialty.coding.code Value Set: UK Core Practice Setting Code |
| LN/81230-5 | Telephone number | 0..1 | string | Definition: PractitionerRole.telecom.value |
| NOS/PreferredReportMethod | Preferred method of report | 0..1 | choice | Options: 2 options |
| NOS/PreferredReportMethod-designNote | Email requires a secure account per the paper form's own footnote - no clean FHIR field identified for this preference. | 0..1 | display | |
| LN/89058-2 | Email/ fax (1) | 0..1 | string | Definition: PractitionerRole.telecom.value |
| NOS/EmailFax2 | Email/ fax (2) | 0..1 | string | Definition: PractitionerRole.telecom.value |
| NOS/EmailFax2-designNote | This form's own second, alternative contact method - maps to a second repeat of PractitionerRole.telecom, distinct from Email/ fax (1) above. | 0..1 | display | |
| NOS/ReportingAddress | Reporting address | 0..1 | string | |
| AskAtOrderEntry | Ask At Order Entry Questions | 0..1 | group | |
 NOS/HRDPathway | Pathway | 1..1 | choice | Definition: ServiceRequest.code Options: 2 options |
 NOS/NewlyDiagnosedAdvancedDiseaseConfirmation | Confirm the patient has newly diagnosed, advanced (FIGO stages III and IV) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer | 0..1 | boolean | Definition: Observation.valueBoolean Enable When: NOS/HRDPathway = Ovarian Carcinoma, HRD status (either positive for BRCA 1 and/or 2, or HRD positive) (NHS England Genomic Test Code#M2.5) |
| NOS/RelapsedDiseaseConfirmation | Confirm the patient has relapsed high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer and has already received one or more treatment for their disease (second line or beyond) | 0..1 | boolean | Definition: Observation.valueBoolean Enable When: NOS/HRDPathway = Ovarian Carcinoma, Multi-target NGS panel - small variant (BRCA1, BRCA2, SMARCA4) (NHS England Genomic Test Code#M2.1) |
| NOS/MyriadInternationalTransferConsent | Consent obtained for tissue, pathology report and personal details (name, NHS number, date of birth) to be sent to Myriad laboratory in the United States for analysis | 0..1 | boolean | Definition: Observation.valueBoolean Enable When: NOS/HRDPathway = Ovarian Carcinoma, HRD status (either positive for BRCA 1 and/or 2, or HRD positive) (NHS England Genomic Test Code#M2.5) |
| NOS/PathologistName | Pathologist | 0..1 | string | Definition: Observation.valueString |
| NOS/PathologyHospital | Pathology hospital | 0..1 | string | Definition: Observation.valueString |
 NOS/NeoplasticCellContent | Approximate % neoplastic nuclei in tumour area highlighted | 0..1 | quantity | Definition: Observation.valueQuantity |
| NOS/NeoplasticCellContent-designNote | Specimen.accessionIdentifier (pathology block/sample number) is already captured by the common core order form's Specimen group - not repeated here. | 0..1 | display | |
| Documentation for this format | ||||
Options Sets
Answer options for NOS/PreferredReportMethod
Answer options for NOS/HRDPathway
FHIR
FHIRsmith{
"resourceType": "Questionnaire",
"id": "HRDTumourBRCAAskAtOrderEntry",
"meta": {
"profile": [
"https://fhir.nwgenomics.nhs.uk/StructureDefinition/NWQuestionnaire"
]
},
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-versionAlgorithm",
"valueCoding": {
"system": "http://hl7.org/fhir/version-algorithm",
"code": "semver"
}
}
],
"url": "https://fhir.nwgenomics.nhs.uk/Questionnaire/HRDTumourBRCAAskAtOrderEntry",
"version": "2.2.0",
"title": "HRD and Tumour BRCA Ask At Order Entry Questions",
"status": "unknown",
"date": "2026-09-27T08:17:18+00:00",
"publisher": "NHS North West Genomics",
"contact": [
{
"telecom": [
{
"system": "url",
"value": "https://www.nwgenomics.nhs.uk/contact-us"
}
]
}
],
"description": "**For analysis purposes only - not an active or planned project.**\n\n**Ask At Order Entry Questions** for the NW GLH paper **HRD and Tumour BRCA Test\nRequest Form** (GB-27189), used alongside the [common core order\nform](Questionnaire-GenomicTestOrder.html) - see [Order Entry\nQuestions](Questionnaire-GenomicTestOrder.html#order-entry-questions). This\nform is specific to newly-diagnosed advanced high-grade epithelial ovarian,\nfallopian tube or primary peritoneal cancer (HRD test, performed by Myriad\nGenetics Inc. in the United States) and its relapsed-disease tumour BRCA-only\npathway.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "GB",
"display": "United Kingdom of Great Britain and Northern Ireland"
}
]
}
],
"item": [
{
"linkId": "Patient",
"definition": "http://hl7.org/fhir/StructureDefinition/Patient#Patient",
"text": "Patient details",
"type": "group",
"item": [
{
"linkId": "LN/45392-8",
"definition": "http://hl7.org/fhir/StructureDefinition/Patient#Patient.name.given",
"code": [
{
"system": "http://loinc.org",
"code": "45392-8"
}
],
"text": "Forename",
"type": "string"
},
{
"linkId": "LN/45394-4",
"definition": "http://hl7.org/fhir/StructureDefinition/Patient#Patient.name.family",
"code": [
{
"system": "http://loinc.org",
"code": "45394-4"
}
],
"text": "Surname",
"type": "string"
},
{
"linkId": "LN/21112-8",
"definition": "http://hl7.org/fhir/StructureDefinition/Patient#Patient.birthDate",
"code": [
{
"system": "http://loinc.org",
"code": "21112-8"
}
],
"text": "DoB (DD/MM/YY)",
"type": "date"
},
{
"linkId": "LN/46098-0",
"definition": "http://hl7.org/fhir/StructureDefinition/Patient#Patient.gender",
"code": [
{
"system": "http://loinc.org",
"code": "46098-0"
}
],
"text": "Sex",
"type": "choice",
"answerValueSet": "http://hl7.org/fhir/ValueSet/administrative-gender"
},
{
"linkId": "LN/89061-6",
"definition": "http://hl7.org/fhir/StructureDefinition/Patient#Patient.identifier:nhsNumber",
"code": [
{
"system": "http://loinc.org",
"code": "89061-6"
}
],
"text": "NHS number",
"type": "string"
},
{
"linkId": "LN/76435-7",
"definition": "http://hl7.org/fhir/StructureDefinition/Patient#Patient.identifier:MedicalRecordNumber",
"code": [
{
"system": "http://loinc.org",
"code": "76435-7"
}
],
"text": "Hospital number",
"type": "string"
}
]
},
{
"linkId": "HealthcareProfessional",
"definition": "http://hl7.org/fhir/StructureDefinition/PractitionerRole#PractitionerRole",
"text": "Referrers details",
"type": "group",
"item": [
{
"linkId": "LN/18705-4",
"definition": "http://hl7.org/fhir/StructureDefinition/PractitionerRole#PractitionerRole.practitioner.display",
"code": [
{
"system": "http://loinc.org",
"code": "18705-4"
}
],
"text": "Name",
"type": "string"
},
{
"linkId": "NOS/ReferrerPosition",
"text": "Position",
"type": "string",
"item": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/questionnaire-itemControl",
"valueCodeableConcept": {
"coding": [
{
"system": "http://hl7.org/fhir/questionnaire-item-control",
"code": "help"
}
]
}
}
],
"linkId": "NOS/ReferrerPosition-designNote",
"text": "No clean FHIR field identified for the referrer's job title, as distinct from their clinical specialty/department below.",
"type": "display"
}
]
},
{
"linkId": "HL7/ORC-21",
"definition": "http://hl7.org/fhir/StructureDefinition/PractitionerRole#PractitionerRole.organization.identifier.value",
"text": "NHS hospital",
"type": "string"
},
{
"linkId": "LN/18707-0",
"definition": "http://hl7.org/fhir/StructureDefinition/PractitionerRole#PractitionerRole.specialty.coding.code",
"code": [
{
"system": "http://loinc.org",
"code": "18707-0"
}
],
"text": "Department",
"type": "choice",
"answerValueSet": "https://fhir.hl7.org.uk/ValueSet/UKCore-PracticeSettingCode"
},
{
"linkId": "LN/81230-5",
"definition": "http://hl7.org/fhir/StructureDefinition/PractitionerRole#PractitionerRole.telecom.value",
"code": [
{
"system": "http://loinc.org",
"code": "81230-5"
}
],
"text": "Telephone number",
"type": "string"
},
{
"linkId": "NOS/PreferredReportMethod",
"text": "Preferred method of report",
"type": "choice",
"answerOption": [
{
"valueCoding": {
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "ReportMethodEmail"
}
},
{
"valueCoding": {
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "ReportMethodFax"
}
}
],
"item": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/questionnaire-itemControl",
"valueCodeableConcept": {
"coding": [
{
"system": "http://hl7.org/fhir/questionnaire-item-control",
"code": "help"
}
]
}
}
],
"linkId": "NOS/PreferredReportMethod-designNote",
"text": "Email requires a secure account per the paper form's own footnote - no clean FHIR field identified for this preference.",
"type": "display"
}
]
},
{
"linkId": "LN/89058-2",
"definition": "http://hl7.org/fhir/StructureDefinition/PractitionerRole#PractitionerRole.telecom.value",
"code": [
{
"system": "http://loinc.org",
"code": "89058-2",
"display": "Contact email address"
}
],
"text": "Email/ fax (1)",
"type": "string"
},
{
"linkId": "NOS/EmailFax2",
"definition": "http://hl7.org/fhir/StructureDefinition/PractitionerRole#PractitionerRole.telecom.value",
"text": "Email/ fax (2)",
"type": "string",
"item": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/questionnaire-itemControl",
"valueCodeableConcept": {
"coding": [
{
"system": "http://hl7.org/fhir/questionnaire-item-control",
"code": "help"
}
]
}
}
],
"linkId": "NOS/EmailFax2-designNote",
"text": "This form's own second, alternative contact method - maps to a second repeat of PractitionerRole.telecom, distinct from Email/ fax (1) above.",
"type": "display"
}
]
},
{
"linkId": "NOS/ReportingAddress",
"text": "Reporting address",
"type": "string"
}
]
},
{
"linkId": "AskAtOrderEntry",
"text": "Ask At Order Entry Questions",
"type": "group",
"item": [
{
"linkId": "NOS/HRDPathway",
"definition": "http://hl7.org/fhir/StructureDefinition/ServiceRequest#ServiceRequest.code",
"text": "Pathway",
"type": "choice",
"required": true,
"answerOption": [
{
"valueCoding": {
"system": "https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory",
"code": "M2.5",
"display": "HRD status (includes tumour BRCA results)"
}
},
{
"valueCoding": {
"system": "https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory",
"code": "M2.1",
"display": "Tumour BRCA test only"
}
}
]
},
{
"linkId": "NOS/NewlyDiagnosedAdvancedDiseaseConfirmation",
"definition": "http://hl7.org/fhir/StructureDefinition/Observation#Observation.valueBoolean",
"code": [
{
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "NewlyDiagnosedAdvancedDiseaseConfirmation"
}
],
"text": "Confirm the patient has newly diagnosed, advanced (FIGO stages III and IV) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer",
"type": "boolean",
"enableWhen": [
{
"question": "NOS/HRDPathway",
"operator": "=",
"answerCoding": {
"system": "https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory",
"code": "M2.5"
}
}
]
},
{
"linkId": "NOS/RelapsedDiseaseConfirmation",
"definition": "http://hl7.org/fhir/StructureDefinition/Observation#Observation.valueBoolean",
"code": [
{
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "RelapsedDiseaseConfirmation"
}
],
"text": "Confirm the patient has relapsed high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer and has already received one or more treatment for their disease (second line or beyond)",
"type": "boolean",
"enableWhen": [
{
"question": "NOS/HRDPathway",
"operator": "=",
"answerCoding": {
"system": "https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory",
"code": "M2.1"
}
}
]
},
{
"linkId": "NOS/MyriadInternationalTransferConsent",
"definition": "http://hl7.org/fhir/StructureDefinition/Observation#Observation.valueBoolean",
"code": [
{
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "MyriadInternationalTransferConsent"
}
],
"text": "Consent obtained for tissue, pathology report and personal details (name, NHS number, date of birth) to be sent to Myriad laboratory in the United States for analysis",
"type": "boolean",
"enableWhen": [
{
"question": "NOS/HRDPathway",
"operator": "=",
"answerCoding": {
"system": "https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory",
"code": "M2.5"
}
}
]
},
{
"linkId": "NOS/PathologistName",
"definition": "http://hl7.org/fhir/StructureDefinition/Observation#Observation.valueString",
"code": [
{
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "PathologistName"
}
],
"text": "Pathologist",
"type": "string"
},
{
"linkId": "NOS/PathologyHospital",
"definition": "http://hl7.org/fhir/StructureDefinition/Observation#Observation.valueString",
"code": [
{
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "PathologyHospital"
}
],
"text": "Pathology hospital",
"type": "string"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/questionnaire-unit",
"valueCoding": {
"system": "http://unitsofmeasure.org",
"code": "%",
"display": "%"
}
}
],
"linkId": "NOS/NeoplasticCellContent",
"definition": "http://hl7.org/fhir/StructureDefinition/Observation#Observation.valueQuantity",
"code": [
{
"system": "https://fhir.nwgenomics.nhs.uk/CodeSystem/NWGMSA",
"code": "NeoplasticCellContent"
}
],
"text": "Approximate % neoplastic nuclei in tumour area highlighted",
"type": "quantity",
"item": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/questionnaire-itemControl",
"valueCodeableConcept": {
"coding": [
{
"system": "http://hl7.org/fhir/questionnaire-item-control",
"code": "help"
}
]
}
}
],
"linkId": "NOS/NeoplasticCellContent-designNote",
"text": "Specimen.accessionIdentifier (pathology block/sample number) is already captured by the common core order form's Specimen group - not repeated here.",
"type": "display"
}
]
}
]
}
]
}